As reported, the balloon of a 6/7f mynx grip vascular closure device (vcd) ruptured during patient use.Hemostasis was achieved by manual compression for less than 30 minutes.There was no reported patient injury.The device was stored and prepared in accordance with the instructions for use.The device was used in an interventional procedure using a retrograde approach.The deployer was mynx certified.The vcd was used with a 6f non-cordis sheath.The femoral artery¿s suitability was verified on angiography, including the insertion angle (30-45 degrees) of the vascular sheath introducer.The vessel diameter was verified to be greater than or equal to 5mm in diameter.There was little vessel tortuosity.There was no presence of peripheral vascular disease or calcium in the vicinity of the puncture site.There was no prior pta, stent, or vascular graft in the common femoral artery or vein.There was no visible damage to the distal end of the sheath after removal.The device will be returned for evaluation.
|
After further review of additional information received the following sections have been updated accordingly: d2, g1, g3, g6, h1, h2, h3 and h6.The balloon of a 6/7f mynx grip vascular closure device (vcd) ruptured during patient use.Hemostasis was achieved by manual compression for less than 30 minutes.There was no reported patient injury.The device was stored and prepared in accordance with the instructions for use.The device was used in an interventional procedure using a retrograde approach.The deployer was mynx certified.The vcd was used with a 6f non-cordis sheath.The femoral artery¿s suitability was verified on angiography, including the insertion angle (30-45 degrees) of the vascular sheath introducer.The vessel diameter was verified to be greater than or equal to 5mm in diameter.There was little vessel tortuosity.There was no presence of peripheral vascular disease or calcium in the vicinity of the puncture site.There was no prior pta, stent, or vascular graft in the common femoral artery or vein.There was no visible damage to the distal end of the sheath after removal.The product was returned for analysis.A non-sterile mynxgrip vascular closure device 6f/7f was returned for investigation inside a clear plastic bag.Per visual analysis the shuttle was disengaged to the black handle.The syringe was received attached with the device and the stopcock was found open.The sealant and advancer tube remained in the manufacturing position.The procedure sheath was not returned.In addition, the balloon was received fully deflated.Per functional analysis an inflation/deflation test was performed which revealed a leak in the balloon of the returned device.Per microscopic analysis a longitudinal tear in the balloon was revealed.The reported ¿balloon loss of pressure¿ was confirmed during analysis of the returned device.The exact cause of the reported event could not be conclusively determined.This type of tear is typically observed when the balloon comes into contact with calcification and/or other procedural devices (such as a damaged procedural sheath, stent or vascular graft).Vessel characteristics may have contributed to the reported event.According to the instructions for use, which is not intended as a mitigation of risk, users are instructed not to use the device if the balloon does not maintain pressure.Neither the event description nor the product analysis suggests that the reported event could be related to the manufacturing process of the unit.Therefore, no corrective actions will be taken at this time.
|